Liquidia (LQDA) Other financing activities (2020 - 2026)

Liquidia's (LQDA) quarterly Other financing activities came in at $1.8 million in Q1 2026, up 38.61% year-on-year from $1.3 million in Q1 2025, and up 87.38% quarter-over-quarter from $935000.0 in Q4 2025.

Liquidia (LQDA) Other financing activities (2020 - 2026) Analysis & Trends

Liquidia's Other financing activities history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.

  • On a quarterly basis, Other financing activities rose 38.61% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 96.19% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 96.52% from the prior year.
  • Other financing activities grew to $1.8 million in Q1 2026 per LQDA's latest filing, from $935000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $135.6 million in Q4 2024 and bottomed at -$71.9 million in Q3 2024.
  • The 5-year median for Other financing activities is $621000.0 (2022), against an average of $8.7 million.
  • Across the five-year window, Other financing activities plunged 133512.5% in 2022 and soared 232290.62% in 2024, its largest moves.
  • Year by year, Other financing activities stood at -$53.4 million in 2022, then surged by 100.15% to $80000.0 in 2023, then surged by 169428.75% to $135.6 million in 2024, then tumbled by 99.31% to $935000.0 in 2025, then soared by 87.38% to $1.8 million in 2026.
  • Per Business Quant, the three latest LQDA Other financing activities figures stand at $1.8 million (Q1 2026), $935000.0 (Q4 2025), and $2.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.75 Mn
Mar 31, 2026 1.75 Mn
Dec 31, 2025 935,000.00
Dec 31, 2025 935,000.00
Sep 30, 2025 2.50 Mn
Sep 30, 2025 2.50 Mn
Jun 30, 2025 125,000.00
Jun 30, 2025 125,000.00
Mar 31, 2025 1.26 Mn
Mar 31, 2025 1.26 Mn
Dec 31, 2024 135.62 Mn
Dec 31, 2024 135.62 Mn
Sep 30, 2024 -71.94 Mn
Sep 30, 2024 -71.94 Mn
Jun 30, 2024 74.37 Mn
Jun 30, 2024 74.37 Mn
Mar 31, 2024 503,000.00
Mar 31, 2024 503,000.00
Dec 31, 2023 80,000.00
Dec 31, 2023 80,000.00